

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.79735006 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 4.83954948 |
| 3 | protein deneddylation (GO:0000338) | 4.38266181 |
| 4 | cullin deneddylation (GO:0010388) | 4.09843709 |
| 5 | viral transcription (GO:0019083) | 4.01200236 |
| 6 | DNA double-strand break processing (GO:0000729) | 3.92811789 |
| 7 | ribosomal small subunit biogenesis (GO:0042274) | 3.89664714 |
| 8 | cotranslational protein targeting to membrane (GO:0006613) | 3.86414400 |
| 9 | translational termination (GO:0006415) | 3.85524827 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.84883990 |
| 11 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.83415225 |
| 12 | protein targeting to ER (GO:0045047) | 3.78089606 |
| 13 | platelet dense granule organization (GO:0060155) | 3.76248843 |
| 14 | proteasome assembly (GO:0043248) | 3.76007270 |
| 15 | positive regulation of mitochondrial fission (GO:0090141) | 3.71047958 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.69529855 |
| 17 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.68378097 |
| 18 | protein localization to endoplasmic reticulum (GO:0070972) | 3.65305441 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.61663087 |
| 20 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.58521179 |
| 21 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.54170469 |
| 22 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.54170469 |
| 23 | termination of RNA polymerase III transcription (GO:0006386) | 3.43625011 |
| 24 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.43625011 |
| 25 | histone H2A acetylation (GO:0043968) | 3.39586168 |
| 26 | sequestering of actin monomers (GO:0042989) | 3.37772320 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.34425542 |
| 28 | immunoglobulin mediated immune response (GO:0016064) | 3.33805641 |
| 29 | neutrophil activation involved in immune response (GO:0002283) | 3.32222977 |
| 30 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.29629646 |
| 31 | respiratory chain complex IV assembly (GO:0008535) | 3.28196977 |
| 32 | positive regulation of B cell differentiation (GO:0045579) | 3.26520895 |
| 33 | mannosylation (GO:0097502) | 3.23926670 |
| 34 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.22156646 |
| 35 | DNA deamination (GO:0045006) | 3.21640958 |
| 36 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.18989071 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.18989071 |
| 38 | response to pheromone (GO:0019236) | 3.18443703 |
| 39 | translational elongation (GO:0006414) | 3.17338786 |
| 40 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.15448333 |
| 41 | intraciliary transport (GO:0042073) | 3.14825034 |
| 42 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.14480119 |
| 43 | response to interferon-beta (GO:0035456) | 3.13782032 |
| 44 | signal peptide processing (GO:0006465) | 3.12678316 |
| 45 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.12335144 |
| 46 | viral life cycle (GO:0019058) | 3.10134426 |
| 47 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.08612052 |
| 48 | protein neddylation (GO:0045116) | 3.08369081 |
| 49 | GPI anchor metabolic process (GO:0006505) | 3.06787542 |
| 50 | regulation of cilium movement (GO:0003352) | 3.06096714 |
| 51 | nonmotile primary cilium assembly (GO:0035058) | 3.05338639 |
| 52 | protein localization to cilium (GO:0061512) | 3.04925057 |
| 53 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.04792399 |
| 54 | retinal cone cell development (GO:0046549) | 3.03797134 |
| 55 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.01366180 |
| 56 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.01366180 |
| 57 | cilium morphogenesis (GO:0060271) | 3.00345753 |
| 58 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.99084707 |
| 59 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.98004920 |
| 60 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.98004920 |
| 61 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.98004920 |
| 62 | cellular protein complex disassembly (GO:0043624) | 2.96985222 |
| 63 | cytochrome complex assembly (GO:0017004) | 2.96247356 |
| 64 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.96101822 |
| 65 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.95037525 |
| 66 | S-adenosylmethionine metabolic process (GO:0046500) | 2.94694207 |
| 67 | neural tube formation (GO:0001841) | 2.94465607 |
| 68 | organelle disassembly (GO:1903008) | 2.93643601 |
| 69 | C-terminal protein amino acid modification (GO:0018410) | 2.93015720 |
| 70 | protein-cofactor linkage (GO:0018065) | 2.92533608 |
| 71 | protein polyglutamylation (GO:0018095) | 2.92005641 |
| 72 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.89361333 |
| 73 | negative regulation of ligase activity (GO:0051352) | 2.89361333 |
| 74 | anterograde synaptic vesicle transport (GO:0048490) | 2.88154223 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 2.87397907 |
| 76 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.86108958 |
| 77 | regulation of hexokinase activity (GO:1903299) | 2.86092271 |
| 78 | regulation of glucokinase activity (GO:0033131) | 2.86092271 |
| 79 | axoneme assembly (GO:0035082) | 2.85249364 |
| 80 | lymphoid progenitor cell differentiation (GO:0002320) | 2.84996498 |
| 81 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.84864302 |
| 82 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83035535 |
| 83 | piRNA metabolic process (GO:0034587) | 2.82244897 |
| 84 | translation (GO:0006412) | 2.82041424 |
| 85 | DNA integration (GO:0015074) | 2.80246469 |
| 86 | L-fucose catabolic process (GO:0042355) | 2.80196663 |
| 87 | fucose catabolic process (GO:0019317) | 2.80196663 |
| 88 | L-fucose metabolic process (GO:0042354) | 2.80196663 |
| 89 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.79212734 |
| 90 | chaperone-mediated protein transport (GO:0072321) | 2.78580363 |
| 91 | maturation of SSU-rRNA (GO:0030490) | 2.78190601 |
| 92 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.77970972 |
| 93 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.77970972 |
| 94 | ubiquinone metabolic process (GO:0006743) | 2.77904832 |
| 95 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.77331079 |
| 96 | cellular response to interferon-beta (GO:0035458) | 2.77181580 |
| 97 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.76725192 |
| 98 | ubiquinone biosynthetic process (GO:0006744) | 2.76496364 |
| 99 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.75954037 |
| 100 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.75654612 |
| 101 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.75054650 |
| 102 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.74394658 |
| 103 | metallo-sulfur cluster assembly (GO:0031163) | 2.72169919 |
| 104 | iron-sulfur cluster assembly (GO:0016226) | 2.72169919 |
| 105 | telomere maintenance via recombination (GO:0000722) | 2.71975917 |
| 106 | ribonucleoprotein complex disassembly (GO:0032988) | 2.70973675 |
| 107 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.69733801 |
| 108 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.69322467 |
| 109 | NADH dehydrogenase complex assembly (GO:0010257) | 2.69322467 |
| 110 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.69322467 |
| 111 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.69321084 |
| 112 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.69321084 |
| 113 | defense response to protozoan (GO:0042832) | 2.69231456 |
| 114 | limb bud formation (GO:0060174) | 2.69061420 |
| 115 | regulation of B cell differentiation (GO:0045577) | 2.68545542 |
| 116 | olfactory bulb development (GO:0021772) | 2.68301420 |
| 117 | translational initiation (GO:0006413) | 2.68175620 |
| 118 | cornea development in camera-type eye (GO:0061303) | 2.67404517 |
| 119 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.66698366 |
| 120 | C-terminal protein lipidation (GO:0006501) | 2.65815382 |
| 121 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.65648712 |
| 122 | branched-chain amino acid catabolic process (GO:0009083) | 2.65564977 |
| 123 | peroxisome fission (GO:0016559) | 2.64249134 |
| 124 | protein complex biogenesis (GO:0070271) | 2.63877056 |
| 125 | glycosphingolipid biosynthetic process (GO:0006688) | 2.62449499 |
| 126 | glycolipid biosynthetic process (GO:0009247) | 2.61257106 |
| 127 | DNA damage response, detection of DNA damage (GO:0042769) | 2.60918458 |
| 128 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.59682122 |
| 129 | regulation of cellular amine metabolic process (GO:0033238) | 2.59048326 |
| 130 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.58976974 |
| 131 | response to protozoan (GO:0001562) | 2.58479386 |
| 132 | positive regulation of ligase activity (GO:0051351) | 2.57574124 |
| 133 | presynaptic membrane assembly (GO:0097105) | 2.57542531 |
| 134 | 7-methylguanosine mRNA capping (GO:0006370) | 2.56813516 |
| 135 | nucleoside transmembrane transport (GO:1901642) | 2.56047465 |
| 136 | ribosomal large subunit biogenesis (GO:0042273) | 2.55733569 |
| 137 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.54705876 |
| 138 | peptidyl-histidine modification (GO:0018202) | 2.54683518 |
| 139 | nucleobase catabolic process (GO:0046113) | 2.53456244 |
| 140 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.53234338 |
| 141 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.53195102 |
| 142 | behavioral response to nicotine (GO:0035095) | 2.53050358 |
| 143 | L-methionine salvage (GO:0071267) | 2.52947098 |
| 144 | L-methionine biosynthetic process (GO:0071265) | 2.52947098 |
| 145 | amino acid salvage (GO:0043102) | 2.52947098 |
| 146 | RNA capping (GO:0036260) | 2.52547284 |
| 147 | 7-methylguanosine RNA capping (GO:0009452) | 2.52547284 |
| 148 | central nervous system myelination (GO:0022010) | 2.52293961 |
| 149 | axon ensheathment in central nervous system (GO:0032291) | 2.52293961 |
| 150 | nucleotide transmembrane transport (GO:1901679) | 2.50431869 |
| 151 | respiratory electron transport chain (GO:0022904) | 2.49620590 |
| 152 | GTP biosynthetic process (GO:0006183) | 2.49202129 |
| 153 | mast cell activation (GO:0045576) | 2.48816825 |
| 154 | DNA strand elongation (GO:0022616) | 2.48584253 |
| 155 | protein targeting to membrane (GO:0006612) | 2.46525522 |
| 156 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.46373354 |
| 157 | rRNA modification (GO:0000154) | 2.46217692 |
| 158 | positive regulation of interleukin-17 production (GO:0032740) | 2.43165615 |
| 159 | electron transport chain (GO:0022900) | 2.42922424 |
| 160 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.42880829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.22198426 |
| 2 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.93044353 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.92548700 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.44948841 |
| 5 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.41598208 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40060424 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.26234360 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.19555171 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97883003 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.94004515 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.89309536 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79947055 |
| 13 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.76676673 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.74415357 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.73761871 |
| 16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.72561577 |
| 17 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.68125614 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.60032625 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.57043515 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.56201346 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.54616297 |
| 22 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.54486439 |
| 23 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.51374363 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.51287674 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.45168563 |
| 26 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.42785777 |
| 27 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.41806177 |
| 28 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.40213450 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.31731740 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 2.30038002 |
| 31 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.27428484 |
| 32 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.26195529 |
| 33 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.26175352 |
| 34 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.21603128 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.19794171 |
| 36 | EWS_26573619_Chip-Seq_HEK293_Human | 2.19318306 |
| 37 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.18612283 |
| 38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.13887239 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.13692957 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.13597787 |
| 41 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.10042220 |
| 42 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09042136 |
| 43 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.06240480 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 2.05199243 |
| 45 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01015825 |
| 46 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.99731937 |
| 47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99525468 |
| 48 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91589651 |
| 49 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88679768 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.87069916 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.82284821 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81313338 |
| 53 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.79195086 |
| 54 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78619355 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.73068737 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.72833422 |
| 57 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72646923 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70834621 |
| 59 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70062565 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.69984087 |
| 61 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67443962 |
| 62 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.62970049 |
| 63 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.62599263 |
| 64 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48583887 |
| 65 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.45664872 |
| 66 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.45629023 |
| 67 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.44866105 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44029716 |
| 69 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43903696 |
| 70 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42599438 |
| 71 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42599438 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41448142 |
| 73 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.41197078 |
| 74 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.40869826 |
| 75 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40782693 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40220060 |
| 77 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.39763625 |
| 78 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36582957 |
| 79 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36030881 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35119660 |
| 81 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.34460300 |
| 82 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.33782834 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32673455 |
| 84 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32334344 |
| 85 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29828360 |
| 86 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29268551 |
| 87 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.29065936 |
| 88 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28730538 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28243702 |
| 90 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27208055 |
| 91 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27208055 |
| 92 | * ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.26609491 |
| 93 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.26068200 |
| 94 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25688106 |
| 95 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.25010868 |
| 96 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23614407 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21177712 |
| 98 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19612693 |
| 99 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.19477050 |
| 100 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19250066 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.18695057 |
| 102 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18403428 |
| 103 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18403428 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17670184 |
| 105 | MYB_26560356_Chip-Seq_TH2_Human | 1.16673544 |
| 106 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.15775013 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15712078 |
| 108 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15349189 |
| 109 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.14986776 |
| 110 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.14531353 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14371694 |
| 112 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.14367341 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13615867 |
| 114 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13488167 |
| 115 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.13488107 |
| 116 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.10740817 |
| 117 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09425530 |
| 118 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09320273 |
| 119 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09015537 |
| 120 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08454129 |
| 121 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.06565774 |
| 122 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06369861 |
| 123 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04439463 |
| 124 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03958453 |
| 125 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.03830947 |
| 126 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03510207 |
| 127 | AR_20517297_ChIP-Seq_VCAP_Human | 1.01642568 |
| 128 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00563157 |
| 129 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00279467 |
| 130 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.99764926 |
| 131 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99701922 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99482330 |
| 133 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98836940 |
| 134 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.98467887 |
| 135 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.98345817 |
| 136 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97663005 |
| 137 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97466176 |
| 138 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.97292648 |
| 139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96769531 |
| 140 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96294474 |
| 141 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.94708150 |
| 142 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93909979 |
| 143 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.93339777 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92178274 |
| 145 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.91874838 |
| 146 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91778234 |
| 147 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.91537510 |
| 148 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.91117735 |
| 149 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.90956996 |
| 150 | NCOR_22424771_ChIP-Seq_293T_Human | 0.90611657 |
| 151 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90567672 |
| 152 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90073485 |
| 153 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.89733092 |
| 154 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.89530028 |
| 155 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88850390 |
| 156 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.88604526 |
| 157 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88039533 |
| 158 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87456099 |
| 159 | GATA3_26560356_Chip-Seq_TH2_Human | 0.86075412 |
| 160 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81961264 |
| 161 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.81925591 |
| 162 | MYB_26560356_Chip-Seq_TH1_Human | 0.81277567 |
| 163 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80843854 |
| 164 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.80334375 |
| 165 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80000536 |
| 166 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77633492 |
| 167 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.77321662 |
| 168 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.77196937 |
| 169 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.76833046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.79410341 |
| 2 | MP0005671_abnormal_response_to | 3.60314505 |
| 3 | MP0009785_altered_susceptibility_to | 3.43120289 |
| 4 | MP0006072_abnormal_retinal_apoptosis | 3.11267530 |
| 5 | MP0008877_abnormal_DNA_methylation | 3.02971921 |
| 6 | MP0000685_abnormal_immune_system | 2.83140913 |
| 7 | MP0002148_abnormal_hypersensitivity_rea | 2.79375452 |
| 8 | MP0001984_abnormal_olfaction | 2.75506442 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.59294887 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.56230384 |
| 11 | MP0008789_abnormal_olfactory_epithelium | 2.50146666 |
| 12 | MP0005025_abnormal_response_to | 2.44954675 |
| 13 | MP0003724_increased_susceptibility_to | 2.43778960 |
| 14 | MP0002723_abnormal_immune_serum | 2.35740166 |
| 15 | MP0005253_abnormal_eye_physiology | 2.34807720 |
| 16 | MP0000372_irregular_coat_pigmentation | 2.32465165 |
| 17 | MP0003787_abnormal_imprinting | 2.30936489 |
| 18 | MP0001800_abnormal_humoral_immune | 2.28224910 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.27093308 |
| 20 | MP0003436_decreased_susceptibility_to | 2.23856311 |
| 21 | MP0002419_abnormal_innate_immunity | 2.20965252 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.20568473 |
| 23 | MP0003195_calcinosis | 2.20082054 |
| 24 | MP0001819_abnormal_immune_cell | 2.18708339 |
| 25 | MP0001986_abnormal_taste_sensitivity | 2.18012277 |
| 26 | MP0005387_immune_system_phenotype | 2.16818363 |
| 27 | MP0001790_abnormal_immune_system | 2.16818363 |
| 28 | MP0002396_abnormal_hematopoietic_system | 2.14099370 |
| 29 | MP0004147_increased_porphyrin_level | 2.11895066 |
| 30 | MP0005394_taste/olfaction_phenotype | 2.08227692 |
| 31 | MP0005499_abnormal_olfactory_system | 2.08227692 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 2.05455316 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 2.01378058 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.89090856 |
| 35 | MP0003763_abnormal_thymus_physiology | 1.88086150 |
| 36 | MP0001905_abnormal_dopamine_level | 1.85842569 |
| 37 | MP0002736_abnormal_nociception_after | 1.85757523 |
| 38 | MP0006292_abnormal_olfactory_placode | 1.85155499 |
| 39 | MP0005645_abnormal_hypothalamus_physiol | 1.84663234 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.79042492 |
| 41 | MP0000015_abnormal_ear_pigmentation | 1.78692929 |
| 42 | MP0002398_abnormal_bone_marrow | 1.77266875 |
| 43 | MP0000716_abnormal_immune_system | 1.77237199 |
| 44 | MP0003879_abnormal_hair_cell | 1.76605576 |
| 45 | MP0002132_abnormal_respiratory_system | 1.76360248 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.75864479 |
| 47 | MP0006082_CNS_inflammation | 1.74625661 |
| 48 | MP0003011_delayed_dark_adaptation | 1.69106183 |
| 49 | MP0001853_heart_inflammation | 1.68948121 |
| 50 | MP0001968_abnormal_touch/_nociception | 1.68409044 |
| 51 | MP0003122_maternal_imprinting | 1.68222399 |
| 52 | MP0005464_abnormal_platelet_physiology | 1.66497305 |
| 53 | MP0004133_heterotaxia | 1.65373929 |
| 54 | MP0002751_abnormal_autonomic_nervous | 1.65117633 |
| 55 | MP0003186_abnormal_redox_activity | 1.64906742 |
| 56 | MP0002095_abnormal_skin_pigmentation | 1.58799071 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.57817211 |
| 58 | MP0003121_genomic_imprinting | 1.55848828 |
| 59 | MP0002429_abnormal_blood_cell | 1.54449880 |
| 60 | MP0005367_renal/urinary_system_phenotyp | 1.53957885 |
| 61 | MP0000516_abnormal_urinary_system | 1.53957885 |
| 62 | MP0002933_joint_inflammation | 1.52593675 |
| 63 | MP0001529_abnormal_vocalization | 1.52489714 |
| 64 | MP0008260_abnormal_autophagy | 1.51240079 |
| 65 | MP0003136_yellow_coat_color | 1.49923399 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 1.49754605 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.45710758 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 1.45514819 |
| 69 | MP0001545_abnormal_hematopoietic_system | 1.45514819 |
| 70 | MP0000647_abnormal_sebaceous_gland | 1.42386810 |
| 71 | MP0003880_abnormal_central_pattern | 1.42245691 |
| 72 | MP0003693_abnormal_embryo_hatching | 1.40788295 |
| 73 | MP0001873_stomach_inflammation | 1.40658432 |
| 74 | MP0003866_abnormal_defecation | 1.39496617 |
| 75 | MP0002722_abnormal_immune_system | 1.38817736 |
| 76 | MP0003718_maternal_effect | 1.37687914 |
| 77 | MP0000920_abnormal_myelination | 1.36847890 |
| 78 | MP0008058_abnormal_DNA_repair | 1.35935694 |
| 79 | MP0006054_spinal_hemorrhage | 1.34868734 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 1.34527125 |
| 81 | MP0001188_hyperpigmentation | 1.34233325 |
| 82 | MP0002405_respiratory_system_inflammati | 1.33247741 |
| 83 | MP0009046_muscle_twitch | 1.32773886 |
| 84 | MP0005409_darkened_coat_color | 1.32599579 |
| 85 | MP0000681_abnormal_thyroid_gland | 1.32447822 |
| 86 | MP0002234_abnormal_pharynx_morphology | 1.31478504 |
| 87 | MP0010155_abnormal_intestine_physiology | 1.31125061 |
| 88 | MP0005646_abnormal_pituitary_gland | 1.30969357 |
| 89 | MP0010386_abnormal_urinary_bladder | 1.29566897 |
| 90 | MP0001845_abnormal_inflammatory_respons | 1.27809910 |
| 91 | MP0000490_abnormal_crypts_of | 1.26545264 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 1.24647418 |
| 93 | MP0008995_early_reproductive_senescence | 1.22755557 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 1.21515305 |
| 95 | MP0008469_abnormal_protein_level | 1.20095168 |
| 96 | MP0005386_behavior/neurological_phenoty | 1.18420280 |
| 97 | MP0004924_abnormal_behavior | 1.18420280 |
| 98 | MP0001764_abnormal_homeostasis | 1.17893724 |
| 99 | MP0008057_abnormal_DNA_replication | 1.17454387 |
| 100 | MP0002090_abnormal_vision | 1.16385967 |
| 101 | MP0002006_tumorigenesis | 1.13887279 |
| 102 | MP0006036_abnormal_mitochondrial_physio | 1.12992288 |
| 103 | MP0002272_abnormal_nervous_system | 1.12023660 |
| 104 | MP0001486_abnormal_startle_reflex | 1.11885160 |
| 105 | MP0002822_catalepsy | 1.11350934 |
| 106 | MP0000427_abnormal_hair_cycle | 1.09618281 |
| 107 | MP0001929_abnormal_gametogenesis | 1.09578142 |
| 108 | MP0003137_abnormal_impulse_conducting | 1.08868959 |
| 109 | MP0005248_abnormal_Harderian_gland | 1.08212873 |
| 110 | MP0001533_abnormal_skeleton_physiology | 1.07937221 |
| 111 | MP0002166_altered_tumor_susceptibility | 1.07608221 |
| 112 | MP0009745_abnormal_behavioral_response | 1.03752021 |
| 113 | MP0002557_abnormal_social/conspecific_i | 1.03461744 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 1.02890513 |
| 115 | MP0005389_reproductive_system_phenotype | 1.01866762 |
| 116 | MP0002938_white_spotting | 1.01550844 |
| 117 | MP0002876_abnormal_thyroid_physiology | 1.01177537 |
| 118 | MP0008872_abnormal_physiological_respon | 1.00507122 |
| 119 | MP0004215_abnormal_myocardial_fiber | 1.00073910 |
| 120 | MP0004142_abnormal_muscle_tone | 0.99887762 |
| 121 | MP0002210_abnormal_sex_determination | 0.99253915 |
| 122 | MP0002163_abnormal_gland_morphology | 0.97683987 |
| 123 | MP0004381_abnormal_hair_follicle | 0.96991993 |
| 124 | MP0005410_abnormal_fertilization | 0.95935541 |
| 125 | MP0005391_vision/eye_phenotype | 0.95479976 |
| 126 | MP0005451_abnormal_body_composition | 0.95240813 |
| 127 | MP0002909_abnormal_adrenal_gland | 0.94760600 |
| 128 | MP0003698_abnormal_male_reproductive | 0.94622705 |
| 129 | MP0005195_abnormal_posterior_eye | 0.94257339 |
| 130 | MP0005171_absent_coat_pigmentation | 0.94097011 |
| 131 | MP0000653_abnormal_sex_gland | 0.92983255 |
| 132 | MP0002233_abnormal_nose_morphology | 0.92639467 |
| 133 | MP0002735_abnormal_chemical_nociception | 0.92199858 |
| 134 | MP0004885_abnormal_endolymph | 0.91178040 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.90512339 |
| 136 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89110352 |
| 137 | MP0008007_abnormal_cellular_replicative | 0.89026925 |
| 138 | MP0000703_abnormal_thymus_morphology | 0.88743322 |
| 139 | MP0003786_premature_aging | 0.87932258 |
| 140 | MP0003077_abnormal_cell_cycle | 0.87152396 |
| 141 | MP0000049_abnormal_middle_ear | 0.86780322 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.86252645 |
| 143 | MP0001293_anophthalmia | 0.85988923 |
| 144 | MP0001919_abnormal_reproductive_system | 0.85866877 |
| 145 | MP0000569_abnormal_digit_pigmentation | 0.85829968 |
| 146 | MP0004947_skin_inflammation | 0.85670588 |
| 147 | MP0001145_abnormal_male_reproductive | 0.84802203 |
| 148 | MP0002572_abnormal_emotion/affect_behav | 0.84607502 |
| 149 | MP0001970_abnormal_pain_threshold | 0.83927304 |
| 150 | MP0000778_abnormal_nervous_system | 0.83723888 |
| 151 | MP0004957_abnormal_blastocyst_morpholog | 0.83574868 |
| 152 | MP0005379_endocrine/exocrine_gland_phen | 0.82965309 |
| 153 | MP0001324_abnormal_eye_pigmentation | 0.81557765 |
| 154 | MP0002160_abnormal_reproductive_system | 0.79733887 |
| 155 | MP0000465_gastrointestinal_hemorrhage | 0.79104487 |
| 156 | MP0005058_abnormal_lysosome_morphology | 0.78993832 |
| 157 | MP0001119_abnormal_female_reproductive | 0.77977682 |
| 158 | MP0002102_abnormal_ear_morphology | 0.77385857 |
| 159 | MP0009764_decreased_sensitivity_to | 0.77078175 |
| 160 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76905611 |
| 161 | MP0010094_abnormal_chromosome_stability | 0.76047172 |
| 162 | MP0002752_abnormal_somatic_nervous | 0.75984930 |
| 163 | MP0004043_abnormal_pH_regulation | 0.75636802 |
| 164 | MP0002734_abnormal_mechanical_nocicepti | 0.75204747 |
| 165 | MP0010678_abnormal_skin_adnexa | 0.75155973 |
| 166 | MP0001485_abnormal_pinna_reflex | 0.75129054 |
| 167 | MP0004742_abnormal_vestibular_system | 0.73857071 |
| 168 | MP0002638_abnormal_pupillary_reflex | 0.72488473 |
| 169 | MP0008932_abnormal_embryonic_tissue | 0.71603674 |
| 170 | MP0004782_abnormal_surfactant_physiolog | 0.71385824 |
| 171 | MP0000858_altered_metastatic_potential | 0.71046101 |
| 172 | MP0005310_abnormal_salivary_gland | 0.70001594 |
| 173 | MP0000566_synostosis | 0.69392364 |
| 174 | MP0005164_abnormal_response_to | 0.67009987 |
| 175 | MP0001851_eye_inflammation | 0.66504889 |
| 176 | MP0009697_abnormal_copulation | 0.65215457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplastic anemia (HP:0001915) | 4.75027743 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 4.27557583 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.26817421 |
| 4 | Type I transferrin isoform profile (HP:0003642) | 4.16433780 |
| 5 | Reduced antithrombin III activity (HP:0001976) | 3.83987424 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.59660621 |
| 7 | Medial flaring of the eyebrow (HP:0010747) | 3.56836299 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.55088971 |
| 9 | Methylmalonic acidemia (HP:0002912) | 3.48422464 |
| 10 | Pancreatic cysts (HP:0001737) | 3.46091190 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.40438671 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.40438671 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.39053158 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.36797838 |
| 15 | 3-Methylglutaconic aciduria (HP:0003535) | 3.31043016 |
| 16 | Renal Fanconi syndrome (HP:0001994) | 3.29862177 |
| 17 | Mitochondrial inheritance (HP:0001427) | 3.25547754 |
| 18 | Pancreatic fibrosis (HP:0100732) | 3.20449976 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.19499039 |
| 20 | Abnormality of midbrain morphology (HP:0002418) | 3.18713303 |
| 21 | Molar tooth sign on MRI (HP:0002419) | 3.18713303 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.16499964 |
| 23 | Abnormality of B cell number (HP:0010975) | 3.14450108 |
| 24 | B lymphocytopenia (HP:0010976) | 3.14450108 |
| 25 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.11332563 |
| 26 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.11332563 |
| 27 | Abnormal protein glycosylation (HP:0012346) | 3.11332563 |
| 28 | Abnormal glycosylation (HP:0012345) | 3.11332563 |
| 29 | Reticulocytopenia (HP:0001896) | 3.10046028 |
| 30 | Acute necrotizing encephalopathy (HP:0006965) | 3.06548974 |
| 31 | IgG deficiency (HP:0004315) | 3.00015059 |
| 32 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.99128618 |
| 33 | Parakeratosis (HP:0001036) | 2.98124922 |
| 34 | IgM deficiency (HP:0002850) | 2.98082891 |
| 35 | Congenital primary aphakia (HP:0007707) | 2.95867575 |
| 36 | Methylmalonic aciduria (HP:0012120) | 2.94265387 |
| 37 | Hepatic necrosis (HP:0002605) | 2.92109705 |
| 38 | Gait imbalance (HP:0002141) | 2.92019341 |
| 39 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.88043816 |
| 40 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.87835807 |
| 41 | Pallor (HP:0000980) | 2.87466350 |
| 42 | Exertional dyspnea (HP:0002875) | 2.85328288 |
| 43 | Hypothermia (HP:0002045) | 2.82073870 |
| 44 | Gastrointestinal stroma tumor (HP:0100723) | 2.81606670 |
| 45 | Nephrogenic diabetes insipidus (HP:0009806) | 2.77295365 |
| 46 | Increased CSF lactate (HP:0002490) | 2.76842696 |
| 47 | Abnormality of the labia minora (HP:0012880) | 2.69082415 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.68462520 |
| 49 | Hyperglycinemia (HP:0002154) | 2.62848173 |
| 50 | Lipid accumulation in hepatocytes (HP:0006561) | 2.62757854 |
| 51 | Thrombocytosis (HP:0001894) | 2.61842717 |
| 52 | Nephronophthisis (HP:0000090) | 2.58577477 |
| 53 | Macrocytic anemia (HP:0001972) | 2.57583748 |
| 54 | Chronic otitis media (HP:0000389) | 2.54780641 |
| 55 | Congenital stationary night blindness (HP:0007642) | 2.52495432 |
| 56 | Recurrent skin infections (HP:0001581) | 2.49478241 |
| 57 | Genital tract atresia (HP:0001827) | 2.46521108 |
| 58 | Petechiae (HP:0000967) | 2.45798281 |
| 59 | Recurrent bronchitis (HP:0002837) | 2.45354088 |
| 60 | Cerebral edema (HP:0002181) | 2.45210476 |
| 61 | Renal cortical cysts (HP:0000803) | 2.41298422 |
| 62 | Recurrent pneumonia (HP:0006532) | 2.40547835 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.37315394 |
| 64 | Vaginal atresia (HP:0000148) | 2.37142029 |
| 65 | Intestinal atresia (HP:0011100) | 2.33647728 |
| 66 | Agammaglobulinemia (HP:0004432) | 2.32054248 |
| 67 | Pancytopenia (HP:0001876) | 2.31294263 |
| 68 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.30679616 |
| 69 | Progressive macrocephaly (HP:0004481) | 2.29656759 |
| 70 | Abnormality of the fovea (HP:0000493) | 2.28997919 |
| 71 | Hypoproteinemia (HP:0003075) | 2.28881609 |
| 72 | Increased intramyocellular lipid droplets (HP:0012240) | 2.28632870 |
| 73 | Abnormal biliary tract physiology (HP:0012439) | 2.25392022 |
| 74 | Bile duct proliferation (HP:0001408) | 2.25392022 |
| 75 | Sclerocornea (HP:0000647) | 2.24827119 |
| 76 | Neutropenia (HP:0001875) | 2.24528651 |
| 77 | Myositis (HP:0100614) | 2.22748693 |
| 78 | Obstructive lung disease (HP:0006536) | 2.22706828 |
| 79 | Chronic obstructive pulmonary disease (HP:0006510) | 2.22706828 |
| 80 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.22441796 |
| 81 | Hypoplasia of the fovea (HP:0007750) | 2.22441796 |
| 82 | Type 2 muscle fiber atrophy (HP:0003554) | 2.22368856 |
| 83 | Optic disc pallor (HP:0000543) | 2.22366030 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.21170134 |
| 85 | Vasculitis (HP:0002633) | 2.20014168 |
| 86 | Stomatitis (HP:0010280) | 2.18865344 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18784095 |
| 88 | Abnormality of the renal cortex (HP:0011035) | 2.18355426 |
| 89 | Abnormality of vitamin B metabolism (HP:0004340) | 2.18007462 |
| 90 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.17258049 |
| 91 | Meningitis (HP:0001287) | 2.16064820 |
| 92 | Poor head control (HP:0002421) | 2.15931045 |
| 93 | Hepatosplenomegaly (HP:0001433) | 2.15495184 |
| 94 | Acute encephalopathy (HP:0006846) | 2.15259295 |
| 95 | Eczematoid dermatitis (HP:0000976) | 2.14910120 |
| 96 | Increased serum lactate (HP:0002151) | 2.14757276 |
| 97 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14415708 |
| 98 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.13886036 |
| 99 | Lymphoma (HP:0002665) | 2.13537885 |
| 100 | Lymphopenia (HP:0001888) | 2.13098422 |
| 101 | Poikiloderma (HP:0001029) | 2.12581221 |
| 102 | Panhypogammaglobulinemia (HP:0003139) | 2.11840087 |
| 103 | Degeneration of anterior horn cells (HP:0002398) | 2.10554480 |
| 104 | Abnormality of the anterior horn cell (HP:0006802) | 2.10554480 |
| 105 | Abnormality of the renal medulla (HP:0100957) | 2.09345479 |
| 106 | Thyroid-stimulating hormone excess (HP:0002925) | 2.07037439 |
| 107 | Colon cancer (HP:0003003) | 2.05288461 |
| 108 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.05025014 |
| 109 | Abnormality of renal resorption (HP:0011038) | 2.04384331 |
| 110 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03531187 |
| 111 | Respiratory failure (HP:0002878) | 2.03016477 |
| 112 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.02163910 |
| 113 | Abnormality of macular pigmentation (HP:0008002) | 2.01191306 |
| 114 | Recurrent sinusitis (HP:0011108) | 2.01133210 |
| 115 | Anencephaly (HP:0002323) | 1.99568683 |
| 116 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.99315554 |
| 117 | Abnormality of glycine metabolism (HP:0010895) | 1.99315554 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.99212992 |
| 119 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.98576290 |
| 120 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.97387265 |
| 121 | Abnormality of alanine metabolism (HP:0010916) | 1.97387265 |
| 122 | Hyperalaninemia (HP:0003348) | 1.97387265 |
| 123 | Increased IgM level (HP:0003496) | 1.97216013 |
| 124 | Attenuation of retinal blood vessels (HP:0007843) | 1.96615810 |
| 125 | Metaphyseal dysplasia (HP:0100255) | 1.96463032 |
| 126 | Generalized aminoaciduria (HP:0002909) | 1.95448773 |
| 127 | Short tibia (HP:0005736) | 1.94826526 |
| 128 | Ketoacidosis (HP:0001993) | 1.93975496 |
| 129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.93861763 |
| 130 | Patchy hypopigmentation of hair (HP:0011365) | 1.92786321 |
| 131 | Glycosuria (HP:0003076) | 1.92765495 |
| 132 | Abnormality of urine glucose concentration (HP:0011016) | 1.92765495 |
| 133 | Postaxial hand polydactyly (HP:0001162) | 1.92339826 |
| 134 | Muscle fiber atrophy (HP:0100295) | 1.92250452 |
| 135 | Entropion (HP:0000621) | 1.92050964 |
| 136 | Cerebral hypomyelination (HP:0006808) | 1.91952817 |
| 137 | Respiratory difficulties (HP:0002880) | 1.91540478 |
| 138 | Male pseudohermaphroditism (HP:0000037) | 1.90702674 |
| 139 | Cystic liver disease (HP:0006706) | 1.90087923 |
| 140 | Recurrent viral infections (HP:0004429) | 1.89306571 |
| 141 | Polyphagia (HP:0002591) | 1.88787159 |
| 142 | Postaxial foot polydactyly (HP:0001830) | 1.88020960 |
| 143 | Occipital encephalocele (HP:0002085) | 1.87519708 |
| 144 | Abnormality of the columella (HP:0009929) | 1.86624157 |
| 145 | Tubulointerstitial nephritis (HP:0001970) | 1.86539840 |
| 146 | Thyroiditis (HP:0100646) | 1.86125910 |
| 147 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.85954644 |
| 148 | CNS demyelination (HP:0007305) | 1.85872806 |
| 149 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.85050159 |
| 150 | Dicarboxylic aciduria (HP:0003215) | 1.85050159 |
| 151 | Abnormality of T cell physiology (HP:0011840) | 1.80829842 |
| 152 | Leukodystrophy (HP:0002415) | 1.80265429 |
| 153 | Lethargy (HP:0001254) | 1.80230520 |
| 154 | Microcytic anemia (HP:0001935) | 1.79918660 |
| 155 | Prolonged neonatal jaundice (HP:0006579) | 1.79865132 |
| 156 | Lactic acidosis (HP:0003128) | 1.79563051 |
| 157 | Abnormality of serum amino acid levels (HP:0003112) | 1.78885570 |
| 158 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.78240143 |
| 159 | Purpura (HP:0000979) | 1.78094206 |
| 160 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.77409393 |
| 161 | Birth length less than 3rd percentile (HP:0003561) | 1.77358835 |
| 162 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.76175775 |
| 163 | Recurrent cutaneous fungal infections (HP:0011370) | 1.76175775 |
| 164 | Increased muscle lipid content (HP:0009058) | 1.75717180 |
| 165 | Retinal dysplasia (HP:0007973) | 1.75655615 |
| 166 | True hermaphroditism (HP:0010459) | 1.75462002 |
| 167 | Abnormality of the prostate (HP:0008775) | 1.75419650 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.74900250 |
| 169 | Preaxial hand polydactyly (HP:0001177) | 1.73952048 |
| 170 | Ketosis (HP:0001946) | 1.72631286 |
| 171 | Decreased testicular size (HP:0008734) | 1.71882715 |
| 172 | Congenital hepatic fibrosis (HP:0002612) | 1.71728985 |
| 173 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.71571901 |
| 174 | Dyskinesia (HP:0100660) | 1.71031775 |
| 175 | Broad foot (HP:0001769) | 1.70679344 |
| 176 | Progressive inability to walk (HP:0002505) | 1.69083958 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CAMKK2 | 4.17391254 |
| 2 | MAP4K2 | 3.72537896 |
| 3 | TNIK | 3.29490638 |
| 4 | NME2 | 3.27726183 |
| 5 | TRIM28 | 3.21997751 |
| 6 | FRK | 3.18340223 |
| 7 | STK16 | 2.93317021 |
| 8 | ACVR1B | 2.62192503 |
| 9 | WNK3 | 2.45467487 |
| 10 | NUAK1 | 2.31061610 |
| 11 | PINK1 | 2.25834527 |
| 12 | TXK | 2.25764994 |
| 13 | EIF2AK3 | 2.25253180 |
| 14 | CDK19 | 2.22999510 |
| 15 | MAP4K1 | 2.18735646 |
| 16 | KIT | 2.15907407 |
| 17 | MUSK | 2.09697456 |
| 18 | PIM2 | 2.07589393 |
| 19 | MAP3K12 | 2.06989926 |
| 20 | PBK | 1.98824778 |
| 21 | MAP3K4 | 1.95450119 |
| 22 | TEC | 1.94724759 |
| 23 | MST4 | 1.90519169 |
| 24 | BUB1 | 1.80406028 |
| 25 | CSNK1G2 | 1.76150939 |
| 26 | CAMK1D | 1.75049403 |
| 27 | VRK1 | 1.72224823 |
| 28 | IRAK4 | 1.72167581 |
| 29 | BCKDK | 1.69873823 |
| 30 | EIF2AK1 | 1.62685364 |
| 31 | TBK1 | 1.62371566 |
| 32 | MAP3K14 | 1.59440305 |
| 33 | WEE1 | 1.57153408 |
| 34 | ZAK | 1.56427969 |
| 35 | CSNK1A1L | 1.55903280 |
| 36 | RIPK4 | 1.49503011 |
| 37 | PLK2 | 1.48376633 |
| 38 | IRAK3 | 1.47773924 |
| 39 | CCNB1 | 1.42419660 |
| 40 | ARAF | 1.42010300 |
| 41 | MAPK13 | 1.37218963 |
| 42 | BTK | 1.36583379 |
| 43 | BMPR2 | 1.36353677 |
| 44 | VRK2 | 1.36220431 |
| 45 | NLK | 1.34683650 |
| 46 | MKNK1 | 1.32009489 |
| 47 | JAK3 | 1.28709511 |
| 48 | IKBKB | 1.22679858 |
| 49 | EPHA4 | 1.16404525 |
| 50 | MAP2K7 | 1.13209931 |
| 51 | PLK3 | 1.12684688 |
| 52 | CLK1 | 1.12412246 |
| 53 | MAPKAPK5 | 1.10019310 |
| 54 | IKBKE | 1.09033260 |
| 55 | MARK1 | 1.08672961 |
| 56 | CSF1R | 1.08613679 |
| 57 | RPS6KA4 | 1.07235876 |
| 58 | TYK2 | 1.05771931 |
| 59 | PAK3 | 1.04663273 |
| 60 | LYN | 1.04451110 |
| 61 | KDR | 1.04344249 |
| 62 | SYK | 1.04327786 |
| 63 | BLK | 1.04250380 |
| 64 | TLK1 | 1.01573127 |
| 65 | NEK1 | 1.00029810 |
| 66 | OXSR1 | 0.97490568 |
| 67 | EIF2AK2 | 0.97465730 |
| 68 | PDK2 | 0.93923392 |
| 69 | ADRBK2 | 0.92595687 |
| 70 | PRKCE | 0.89073828 |
| 71 | STK39 | 0.86024877 |
| 72 | CASK | 0.85958990 |
| 73 | TIE1 | 0.85047171 |
| 74 | MAP3K11 | 0.84356379 |
| 75 | BMPR1B | 0.81854543 |
| 76 | ZAP70 | 0.81810943 |
| 77 | NME1 | 0.79768190 |
| 78 | LCK | 0.78576120 |
| 79 | BRSK2 | 0.76953251 |
| 80 | FLT3 | 0.75374121 |
| 81 | PLK1 | 0.74616338 |
| 82 | GRK7 | 0.74097742 |
| 83 | INSRR | 0.73188526 |
| 84 | MKNK2 | 0.72888832 |
| 85 | STK38L | 0.72678271 |
| 86 | FGFR2 | 0.72525355 |
| 87 | MINK1 | 0.71202414 |
| 88 | TAF1 | 0.68071816 |
| 89 | LIMK1 | 0.67386786 |
| 90 | CAMK1G | 0.66788775 |
| 91 | DYRK2 | 0.66663766 |
| 92 | TESK2 | 0.62352699 |
| 93 | CAMK1 | 0.60288379 |
| 94 | CSNK1G3 | 0.59690877 |
| 95 | DAPK1 | 0.58704263 |
| 96 | PRKCG | 0.58359555 |
| 97 | DYRK3 | 0.58353064 |
| 98 | ITK | 0.57745879 |
| 99 | STK3 | 0.57307096 |
| 100 | SRPK1 | 0.56669874 |
| 101 | SIK3 | 0.55357527 |
| 102 | RPS6KA5 | 0.55119269 |
| 103 | ABL2 | 0.54214897 |
| 104 | FER | 0.53396127 |
| 105 | EPHA3 | 0.52421847 |
| 106 | MYLK | 0.51334451 |
| 107 | YES1 | 0.50642082 |
| 108 | CAMKK1 | 0.49414928 |
| 109 | PHKG2 | 0.49128011 |
| 110 | PHKG1 | 0.49128011 |
| 111 | MAPK15 | 0.47795011 |
| 112 | MAP2K3 | 0.47080112 |
| 113 | KSR1 | 0.46050164 |
| 114 | MATK | 0.45645843 |
| 115 | CAMK2A | 0.44737588 |
| 116 | BRAF | 0.44319472 |
| 117 | FES | 0.44254972 |
| 118 | CSNK1A1 | 0.44179864 |
| 119 | LRRK2 | 0.44139531 |
| 120 | RAF1 | 0.43017454 |
| 121 | TAOK3 | 0.42988353 |
| 122 | STK4 | 0.42985016 |
| 123 | PIM1 | 0.42888419 |
| 124 | PLK4 | 0.42521325 |
| 125 | TESK1 | 0.42349832 |
| 126 | WNK4 | 0.41576514 |
| 127 | MAPK4 | 0.40333891 |
| 128 | PKN1 | 0.39504416 |
| 129 | BCR | 0.38974376 |
| 130 | PRKG2 | 0.38179812 |
| 131 | ADRBK1 | 0.37857955 |
| 132 | NTRK2 | 0.37455543 |
| 133 | ERBB3 | 0.37169427 |
| 134 | PRKCD | 0.36708872 |
| 135 | NEK6 | 0.36243730 |
| 136 | PASK | 0.35530597 |
| 137 | STK24 | 0.35283676 |
| 138 | CSNK2A1 | 0.34850040 |
| 139 | MAP3K9 | 0.34676339 |
| 140 | PRKACA | 0.33944044 |
| 141 | TGFBR1 | 0.33859673 |
| 142 | ATR | 0.33839125 |
| 143 | ATM | 0.33773769 |
| 144 | MAP3K5 | 0.33414335 |
| 145 | DAPK2 | 0.32179641 |
| 146 | CSNK1G1 | 0.32159059 |
| 147 | FGR | 0.31178868 |
| 148 | MAP3K13 | 0.31050837 |
| 149 | GRK1 | 0.30480690 |
| 150 | MARK3 | 0.28729778 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.09023235 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.92338693 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.00226082 |
| 4 | DNA replication_Homo sapiens_hsa03030 | 2.99065502 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.95377653 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.74412514 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.67168568 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.57679671 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.54632506 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.33711203 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.26640226 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23990024 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.04061902 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.03448999 |
| 15 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.98112338 |
| 16 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94360180 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.88461638 |
| 18 | Base excision repair_Homo sapiens_hsa03410 | 1.85807418 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.82562524 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.73321665 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.73184296 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.71997294 |
| 23 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.69723120 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.64813239 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60859945 |
| 26 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.58075588 |
| 27 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.56621005 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55517096 |
| 29 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.52388195 |
| 30 | Alzheimers disease_Homo sapiens_hsa05010 | 1.50118584 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.49856950 |
| 32 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.42515488 |
| 33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.41594156 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40383603 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40223643 |
| 36 | Spliceosome_Homo sapiens_hsa03040 | 1.38524956 |
| 37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36453612 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.34259906 |
| 39 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32719907 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.28218413 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.26044585 |
| 42 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24246790 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22946162 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18503843 |
| 45 | Leishmaniasis_Homo sapiens_hsa05140 | 1.17127445 |
| 46 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.15815231 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14722734 |
| 48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.14516732 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10801308 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 1.10408667 |
| 51 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09777653 |
| 52 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09540943 |
| 53 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08439685 |
| 54 | Asthma_Homo sapiens_hsa05310 | 1.01612429 |
| 55 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.99507040 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.98809275 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 0.98047804 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.96673052 |
| 59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96489197 |
| 60 | Malaria_Homo sapiens_hsa05144 | 0.94520612 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.94467786 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.94405024 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.94362392 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.94299015 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.93062546 |
| 66 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92733392 |
| 67 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90209204 |
| 68 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.89349959 |
| 69 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89137198 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.89120616 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88552798 |
| 72 | RNA degradation_Homo sapiens_hsa03018 | 0.88039949 |
| 73 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87997113 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 0.87284808 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85856329 |
| 76 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.84979651 |
| 77 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.84423463 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.81627159 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81612774 |
| 80 | Legionellosis_Homo sapiens_hsa05134 | 0.81262799 |
| 81 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80803109 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.76789877 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74474683 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74392328 |
| 85 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.74318240 |
| 86 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73559329 |
| 87 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.73016663 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72600490 |
| 89 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71663475 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.71502936 |
| 91 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71439480 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | 0.71258575 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.70712264 |
| 94 | RNA transport_Homo sapiens_hsa03013 | 0.70448357 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.69886071 |
| 96 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69279231 |
| 97 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.69224048 |
| 98 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68942805 |
| 99 | Salmonella infection_Homo sapiens_hsa05132 | 0.68232421 |
| 100 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.67945942 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67590401 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.66239473 |
| 103 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64711174 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64099044 |
| 105 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63925271 |
| 106 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63014505 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60161112 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.58611256 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.58132999 |
| 110 | Taste transduction_Homo sapiens_hsa04742 | 0.56346220 |
| 111 | Cell cycle_Homo sapiens_hsa04110 | 0.56310969 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55031432 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.54625391 |
| 114 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.53398963 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52219134 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52020946 |
| 117 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.50986895 |
| 118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50634044 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50375996 |
| 120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47745150 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.47430122 |
| 122 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47372634 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.47305626 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46296937 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45828113 |
| 126 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45360155 |
| 127 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44961378 |
| 128 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41703945 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.41120107 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.39727256 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38150689 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37494061 |
| 133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.37387439 |
| 134 | Lysosome_Homo sapiens_hsa04142 | 0.37298001 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35119171 |
| 136 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.34764988 |
| 137 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.32891552 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32480578 |
| 139 | Circadian rhythm_Homo sapiens_hsa04710 | 0.29861567 |
| 140 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.29466130 |
| 141 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.28418022 |
| 142 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28132537 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27758708 |
| 144 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.26145232 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.26058031 |
| 146 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.25055623 |

